Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.67 |
| ▸ | NPBWR1 | P48145 | 7/20 | 0.61 |
| ▸ | CCKBR | P32239 | 4/20 | 0.60 |
| ▸ | ECE1 | P42892 | 1/20 | 0.60 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 0.60 |
| ▸ | CCKAR | P32238 | 1/20 | 0.58 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.58 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26080243 | 0.99 | GLP1R (0.68) | GLP1RNPBWR1CCKBRECE1MUS81 | |
| SCHEMBL26080241 | 0.99 | GLP1R (0.68) | GLP1RNPBWR1CCKBRECE1MUS81 | |
| SCHEMBL26080387 | 0.99 | GLP1R (0.68) | GLP1RNPBWR1CCKBRECE1MUS81 | |
| SCHEMBL26080249 | 0.99 | GLP1R (0.68) | GLP1RNPBWR1CCKBRECE1MUS81 | |
| SCHEMBL26080259 | 0.96 | NPBWR1 (0.65) | GLP1RNPBWR1CCKBRCCKAROPRD1 | |
| SCHEMBL26080267 | 0.96 | NPBWR1 (0.65) | GLP1RNPBWR1CCKBRCCKAROPRD1 | |
| SCHEMBL26080292 | 0.95 | NPBWR1 (0.64) | GLP1RNPBWR1CCKBRCCKAROPRD1 | |
| SCHEMBL26080270 | 0.95 | NPBWR1 (0.64) | GLP1RNPBWR1CCKBRCCKAROPRD1 | |
| SCHEMBL26080247 | 0.94 | GLP1R (0.65) | GLP1RNPBWR1CCKBRIL23R | |
| SCHEMBL26080264 | 0.94 | NPBWR1 (0.63) | GLP1RNPBWR1CCKBRCCKAROPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230312650-A1 | Antifungal Peptides, Compounds Including The Same, And Methods Of Use Thereof | SETON HALL UNIVERSITY (US) | 2023-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230312650-A1 | Antifungal Peptides, Compounds Including The Same, And Methods Of Use Thereof | ARF5, CDC5L, API5 | GLP1R 3720/4885NPBWR1 3187/4885CCKBR 4885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.